• Quotes
  • Shortcuts
The Executive's Internet
Wed, Jan 22nd
editor corner icon Editor's Corner | Archive
4 Reasons Most Enterprise-Level Businesses (Still) Don't Get Digital Adoption. Patricia
site of the day icon Site of the Day | Archive
Free Online Learning
The freedom to learn what you want, when you want. Check out Everyday Life, Basic Math, and Computer Training today.



Setup News Ticker
Searching for 'Shares 10%'. (Return)

MarketWatch MarketPulseJan 22, 2020
Novavax stock falls after jumping on virus concerns
Shares of Novavax Inc. tumbled 15% in premarket trading on Wednesday following a day in which growing concern about the new coronavirus sent shares of vaccine developers soaring. On Tuesday after the market closed, Novavax filed an S-1 seeking to sell more than $100 million of its stock. The clinical-stage biotechnology company, which is developing a flu vaccine, told analysts it is developing clones from the new coronavirus as part of the first steps in developing a vaccine to treat the newly identified virus. "We don't expect Novavax will run human trials without non-dilutive government funding," Ladenburg Thalmann's Michael Higgens wrote in a note. "The timing for such support in our view depends on how severe and uncontrolled the 2019-nCoV becomes." Novavax in 2013 had developed a vaccine for Middle East respiratory syndrome (MERS), which is also a coronavirus. This coronavirus was first identified in Wuhan City, China, and has infected more than 300 people and killed at least six more. The Centers for Disease Control and Prevention said Tuesday that a U.S. resident who had traveled to Wuhan and is now in Washington state is currently being treated. He is the first U.S. resident to be diagnosed with the virus. Novavax's stock has fallen 75% over the last year, while the SPDR S&P Biotech exchange-traded fund has climbed 13%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Yahoo BusinessJan 22, 2020
Here's What Analysts Are Saying About Netflix's Latest Earnings
(Bloomberg) -- Netflix Inc. shares edged higher in U.S. pre-market trading, though remain far below 2018 and 2019 highs, after a mixed earnings report that showed overseas growth helping to offset a slowdown at home amid increasing competition from Walt Disney Co. and Apple Inc.Analysts were generally positive about the results and, while first-quarter guidance missed estimates, Piper Sandler analyst Michael Olson said that the forecast may be conservative. Netflix added 8.3 million subscribers internationally in the fourth quarter to surpass 100 million paid memberships outside of the U.S. for the first time.Stifel analyst Scott W. Devitt noted that Disney appeared to have a less meaningful impact in available international markets than in the U.S. Still, the analyst cautioned of the potential impact from the broader rollout of Disney in EMEA toward the end of the first quarter.The stock gained 1.2% to $342 a share at 6.13 a.m. in New York.Here's a summary of what some other analysts had to say.Morgan Stanley, Ben SwinburneOverweight, price target $400Update reinforces bullish long-term view and, going forward, analyst expects 90% of global paid net additions to come from outside the U.S., amid continued elevated domestic churn.Notes that local originals were the most popular titles in 2019 in countries including India, Japan, Turkey, Sweden and the U.K.Guidance for nearly $1bn in free cash flow improvement begins the path toward positive FCF and reinforces confidence in the earnings outloo

MarketWatch MarketPulseJan 22, 2020
Express' stock surges after unveiling new 'profitable growth' strategy, to close 100 stores in 2 years
Shares of Express Inc. surged 4.1% in premarket trading Wednesday, after the apparel retailer unveiled a new corporate strategy aimed at profitable growth, narrowed its fiscal fourth-quarter profit outlook and said it will close 100 stores by 2022. The company now expects adjusted earnings per share of 17 cents to 19 cents, compared with the previous guidance range of 16 cents to 21 cents. Express said it expects same-stores sales for the quarter to be down approximately 3% from a year ago, versus previous guidance of down 1% to down 3%. The company said the planned store closures would reduce revenue by $90 million by 2022, but that will be offset by the elimination of costs and by leveraging the remaining stores for additional sales. Express said it has identified $80 million in annualized cost savings, including $55 million through workforce reductions and $25 million through process improvement and inventory optimization. The stock has declined 21.0% over the past 12 months through Tuesday, while the SPDR S&P Retail ETF has gained 4.3% and the S&P 500 has climbed 26.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

TrumpDavos impeachment Fed trial CNBC
Chinavirus coronavirus spread outbreak stocks
stockMarket virus China Tesla coronavirus
BoeingMax return stock forecasts premarket
coronavirusChina case spread stocks Wuhan
NetflixSubscriber Earnings Growth Market Disney
profitJohnson misses estimates forecasts Daimler
SalesJohnson profit IBM Abbott &
&Johnson profit J&J IBM Stocks
MAXBoeing return service delay Airlines

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC